JP2021164407A - Growth stimulator for mesenchymal stem cell - Google Patents
Growth stimulator for mesenchymal stem cell Download PDFInfo
- Publication number
- JP2021164407A JP2021164407A JP2020068105A JP2020068105A JP2021164407A JP 2021164407 A JP2021164407 A JP 2021164407A JP 2020068105 A JP2020068105 A JP 2020068105A JP 2020068105 A JP2020068105 A JP 2020068105A JP 2021164407 A JP2021164407 A JP 2021164407A
- Authority
- JP
- Japan
- Prior art keywords
- mesenchymal stem
- stem cells
- fish
- meat
- tuna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 59
- 239000003324 growth hormone secretagogue Substances 0.000 title abstract 2
- 235000013372 meat Nutrition 0.000 claims abstract description 41
- 241000251468 Actinopterygii Species 0.000 claims abstract description 39
- 235000013305 food Nutrition 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 239000004480 active ingredient Substances 0.000 claims abstract description 10
- 239000007952 growth promoter Substances 0.000 claims description 17
- 230000035755 proliferation Effects 0.000 claims description 13
- 230000001737 promoting effect Effects 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 230000004936 stimulating effect Effects 0.000 abstract 2
- 235000019688 fish Nutrition 0.000 description 36
- 239000000047 product Substances 0.000 description 27
- 239000002699 waste material Substances 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 20
- 235000001014 amino acid Nutrition 0.000 description 17
- 229940024606 amino acid Drugs 0.000 description 17
- 150000001413 amino acids Chemical class 0.000 description 17
- 108090000765 processed proteins & peptides Proteins 0.000 description 17
- 210000000988 bone and bone Anatomy 0.000 description 16
- 102000004196 processed proteins & peptides Human genes 0.000 description 15
- 239000001888 Peptone Substances 0.000 description 13
- 108010080698 Peptones Proteins 0.000 description 13
- 210000001185 bone marrow Anatomy 0.000 description 13
- 235000019319 peptone Nutrition 0.000 description 13
- 229920001184 polypeptide Polymers 0.000 description 12
- 238000012545 processing Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 239000002609 medium Substances 0.000 description 9
- 230000004663 cell proliferation Effects 0.000 description 8
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 8
- 229940066779 peptones Drugs 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 6
- 230000001172 regenerating effect Effects 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000012137 tryptone Substances 0.000 description 5
- 108010076119 Caseins Proteins 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 239000005018 casein Substances 0.000 description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
- 235000021240 caseins Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000002062 proliferating effect Effects 0.000 description 4
- JUJBNYBVVQSIOU-UHFFFAOYSA-M sodium;4-[2-(4-iodophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=N1 JUJBNYBVVQSIOU-UHFFFAOYSA-M 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- 102000015636 Oligopeptides Human genes 0.000 description 3
- 108010038807 Oligopeptides Proteins 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 235000013330 chicken meat Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 108010041308 Endothelial Growth Factors Proteins 0.000 description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- 102000003969 Fibroblast growth factor 4 Human genes 0.000 description 2
- 108090000381 Fibroblast growth factor 4 Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 102000004407 Lactalbumin Human genes 0.000 description 2
- 108090000942 Lactalbumin Proteins 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 241000269851 Sarda sarda Species 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- 230000002900 effect on cell Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000002816 gill Anatomy 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- -1 pH regulators Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 108010009004 proteose-peptone Proteins 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001282110 Pagrus major Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010034203 Pectus Carinatum Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002745 epiphysis Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 238000009931 pascalization Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
本発明は、間葉系幹細胞の増殖を促進させる作用を有する食品組成物および薬剤に関する。 The present invention relates to food compositions and agents having an action of promoting the proliferation of mesenchymal stem cells.
間葉系幹細胞(mesenchymal stem cells:MSC)は、骨細胞、心筋細胞、軟骨細胞、腱細胞、神経細胞および脂肪細胞などの間葉系に属する細胞への分化能を持つ細胞である。間葉系幹細胞は、骨、血管および心筋の再構築など、再生医療への応用が期待されている。 Mesenchymal stem cells (MSCs) are cells capable of differentiating into cells belonging to the mesenchymal system such as bone cells, myocardial cells, cartilage cells, tendon cells, nerve cells and fat cells. Mesenchymal stem cells are expected to be applied to regenerative medicine such as reconstruction of bone, blood vessels and myocardium.
間葉系幹細胞には、免疫調整能が備わっているため、他人由来の間葉系幹細胞から作製した臓器を移植しても拒絶反応が起きない。また、iPS細胞と比較して、間葉系幹細胞を用いた治療では、腫瘍化のリスクが少ないという利点がある。 Since mesenchymal stem cells have an immunomodulatory ability, rejection does not occur even if an organ prepared from mesenchymal stem cells derived from another person is transplanted. In addition, treatment using mesenchymal stem cells has an advantage that the risk of tumorigenesis is lower than that of iPS cells.
間葉系幹細胞は、骨髄および脂肪組織等の種々の組織から取得することができる。採取する臓器によって、得られる間葉系幹細胞の性質が異なることが分かっている。 Mesenchymal stem cells can be obtained from various tissues such as bone marrow and adipose tissue. It is known that the properties of the obtained mesenchymal stem cells differ depending on the organ to be collected.
再生医療に用いるための間葉系幹細胞を増殖させるための技術が求められている。たとえば特許文献1には、間葉系幹細胞を増殖させる方法として、ニコチンアミドと線維芽細胞成長因子4(FGF4)とを含む培地中で、未分化の間葉系幹細胞(MSC)を含むMSCの集団を培養することによって、増殖された未分化のMSCの集団を生成する工程を含み、前記培地は追加で添加された塩基性線維芽細胞成長因子(bFGF)、血小板由来成長因子(PDGF)、および内皮成長因子(EGF)を含まない、未分化のMSCを増殖させる方法が開示されている。
There is a need for a technique for proliferating mesenchymal stem cells for use in regenerative medicine. For example,
また、特許文献2には、間葉系幹細胞(MSC)を増殖させる方法において:(a)細胞を体の組織または臓器から単離するステップと;(b)(a)で得られた前記単離細胞を、アポトーシス誘導剤を含む増殖培地中で少なくとも3日間インキュベートすることによって、MSCが富化された細胞集団を得るステップとを含むことを特徴とする方法が開示されている。
In addition,
再生医療に用いるための間葉系幹細胞を効率よく増殖させるための技術が求められている。 There is a need for a technique for efficiently proliferating mesenchymal stem cells for use in regenerative medicine.
そこで本発明の目的は、間葉系幹細胞の増殖を促進させることができる新たな薬剤を提供することにある。 Therefore, an object of the present invention is to provide a new drug capable of promoting the proliferation of mesenchymal stem cells.
本発明者らは、マグロから可食部を取り除いた廃棄部を100〜300℃の温度および0.1〜8.6MPaの圧力において1〜120分間、高温高圧処理することにより、マグロ廃棄部可溶化物(TWL)を得た。このTWLを骨髄由来間葉系幹細胞(BMSC)に添加して培養したところ、濃度依存的にBMSCの増殖を促進する作用を有することを新たに見出した。 The present inventors have solubilized the tuna waste portion by subjecting the waste portion from which the edible portion has been removed from the tuna to a high temperature and high pressure treatment at a temperature of 100 to 300 ° C. and a pressure of 0.1 to 8.6 MPa for 1 to 120 minutes. TWL) was obtained. When this TWL was added to bone marrow-derived mesenchymal stem cells (BMSC) and cultured, it was newly found that it has a concentration-dependent effect of promoting the growth of BMSC.
本発明は、魚類または食肉を100〜300℃の温度および0.1〜8.6MPaの圧力において1〜120分間処理した処理物を有効成分として含有する、間葉系幹細胞に対する増殖促進剤を提供する。 The present invention provides a growth promoter for mesenchymal stem cells, which comprises a treated product of fish or meat treated at a temperature of 100 to 300 ° C. and a pressure of 0.1 to 8.6 MPa for 1 to 120 minutes as an active ingredient.
また本発明は、上記魚類がマグロである、間葉系幹細胞に対する増殖促進剤を提供する。 The present invention also provides a growth promoter for mesenchymal stem cells, wherein the fish is tuna.
また本発明は、上記魚類がアラである、間葉系幹細胞に対する増殖促進剤を提供する。 The present invention also provides a growth promoter for mesenchymal stem cells, wherein the fish is ara.
また本発明は、魚類または食肉を100〜300℃の温度および0.1〜8.6MPaの圧力において1〜120分間処理した処理物を有効成分として含有する、間葉系幹細胞の増殖を促進するための食品組成物を提供する。 The present invention also comprises a food product for promoting the proliferation of mesenchymal stem cells, which comprises a processed product obtained by treating fish or meat at a temperature of 100 to 300 ° C. and a pressure of 0.1 to 8.6 MPa for 1 to 120 minutes as an active ingredient. The composition is provided.
また本発明は、上記魚類がマグロである食品組成物を提供する。 The present invention also provides a food composition in which the fish is tuna.
また本発明は、上記魚類がアラである食品組成物を提供する。 The present invention also provides a food composition in which the fish is ara.
本発明は、間葉系幹細胞の増殖を促進させる新たな薬剤を提供するため、再生医療に寄与することができる。 The present invention can contribute to regenerative medicine because it provides a new drug that promotes the proliferation of mesenchymal stem cells.
本発明は、魚類または食肉を100〜300℃の温度および0.1〜8.6MPaの圧力において1〜120分間処理した処理物を有効成分として含有する、間葉系幹細胞に対する増殖促進剤を提供する。 The present invention provides a growth promoter for mesenchymal stem cells, which comprises a treated product of fish or meat treated at a temperature of 100 to 300 ° C. and a pressure of 0.1 to 8.6 MPa for 1 to 120 minutes as an active ingredient.
間葉系幹細胞は、間葉系に属する細胞への分化能をもつ細胞である。本明細書において「間葉系幹細胞に対する増殖促進」とは、生体内または生体外において間葉系幹細胞の増殖を促進し、間葉系幹細胞の細胞数を増加させることをいう。 Mesenchymal stem cells are cells capable of differentiating into cells belonging to the mesenchymal system. As used herein, the term "proliferation promotion for mesenchymal stem cells" means promoting the proliferation of mesenchymal stem cells in vivo or in vitro to increase the number of mesenchymal stem cells.
本発明の増殖促進剤は、魚類または食肉を100〜300℃の温度および0.1〜8.6MPaの圧力において1〜120分間処理(すなわち高温高圧処理)した処理物を有効成分として含有する。 The growth promoter of the present invention contains a treated product obtained by treating fish or meat at a temperature of 100 to 300 ° C. and a pressure of 0.1 to 8.6 MPa for 1 to 120 minutes (that is, high temperature and high pressure treatment) as an active ingredient.
本発明における処理物には、高温高圧処理によって魚類または食肉のタンパク質が加水分解されて生成されるポリペプチドが含まれる。本明細書において、ポリペプチドとは、2個以上のアミノ酸がペプチド結合によりつながって構成されるペプチドをいい、オリゴペプチドをも含む概念である。本発明におけるポリペプチドは、タンパク質が加水分解されて生成されたペプチドである本発明における処理物に含まれるポリペプチドの分子量は、10以上、50以上、100以上、たとえば10〜10000であってもよく、好ましくは50〜5000、より好ましくは100〜1000であってもよい。 The processed product in the present invention includes a polypeptide produced by hydrolyzing a protein of fish or meat by high-temperature and high-pressure treatment. As used herein, a polypeptide refers to a peptide in which two or more amino acids are linked by peptide bonds, and is a concept including oligopeptides. The polypeptide in the present invention is a peptide produced by hydrolyzing a protein. Even if the molecular weight of the polypeptide contained in the processed product in the present invention is 10 or more, 50 or more, 100 or more, for example, 10 to 10000. It may be good, preferably 50 to 5000, and more preferably 100 to 1000.
本明細書において、ポリペプチドの分子量を数値範囲によって規定する場合、少なくともポリペプチドの10%以上が当該範囲の中に含まれることを意味し、好ましくはポリペプチドの20%、30%、40%、50%、60%、70%、80%以上、90%以上、さらに好ましくは実質的に全てのポリペプチドの分子量が当該範囲の中に含まれることを意味する。 In the present specification, when the molecular weight of a polypeptide is defined by a numerical range, it means that at least 10% or more of the polypeptide is contained in the range, preferably 20%, 30%, 40% of the polypeptide. , 50%, 60%, 70%, 80% or more, 90% or more, and more preferably the molecular weights of substantially all polypeptides are included in the range.
本発明に使用される高温高圧処理物は、魚類または食肉を100〜300℃の温度および0.1〜8.6MPaの圧力において1〜120分間処理することにより、タンパク質を加水分解して分子量100〜10000のポリペプチドを生成する。本発明に使用される高温高圧処理物は、上述した温度、圧力および時間の組み合わせにおいて魚類または食肉を高温高圧処理することにより、魚類または食肉に含まれるタンパク質を効率よく加水分解し、分子量100〜10000のポリペプチドとして生成される。 The high-temperature and high-pressure treated product used in the present invention hydrolyzes proteins by treating fish or meat at a temperature of 100 to 300 ° C. and a pressure of 0.1 to 8.6 MPa for 1 to 120 minutes to have a molecular weight of 100 to 10000. Produces a polypeptide. The high-temperature and high-pressure processed product used in the present invention efficiently hydrolyzes proteins contained in fish or meat by subjecting fish or meat to high-temperature and high-pressure treatment at the above-mentioned combination of temperature, pressure and time, and has a molecular weight of 100 to 100. Produced as 10000 polypeptides.
本発明において魚類または食肉を処理する際の温度は、100〜300℃であり、好ましくは130〜300℃、より好ましくは150〜250℃である。また、魚類または食肉を処理する際の圧力は、0.1〜8.6MPaであり、好ましくは0.2〜4.0MPaである。また、魚類または食肉を処理する時間は、1〜120分間である。 In the present invention, the temperature at which fish or meat is processed is 100 to 300 ° C, preferably 130 to 300 ° C, and more preferably 150 to 250 ° C. The pressure for processing fish or meat is 0.1 to 8.6 MPa, preferably 0.2 to 4.0 MPa. The time for processing fish or meat is 1 to 120 minutes.
魚類または食肉を処理する時間は、魚類または食肉を処理する温度に応じて適切に設定することができる。たとえば処理時間は、処理温度が低い場合には長く、処理温度が高い場合には短く設定してもよい。たとえば、処理温度が100〜180℃のとき、処理時間を60〜120分に設定してもよく、処理温度が180〜220℃のとき、処理時間を20〜60分に設定してもよく、処理温度が220〜300℃のとき、処理時間を1〜20分に設定してもよい。温度および時間をこのように設定することにより、タンパク質を適度に加水分解させ、タンパク質の可溶化率を上昇させることができる。その結果、分子量100〜10000のポリペプチドを効率よく生成することができる。 The time for processing the fish or meat can be appropriately set according to the temperature at which the fish or meat is processed. For example, the processing time may be set long when the processing temperature is low and short when the processing temperature is high. For example, when the processing temperature is 100 to 180 ° C, the processing time may be set to 60 to 120 minutes, and when the processing temperature is 180 to 220 ° C, the processing time may be set to 20 to 60 minutes. When the processing temperature is 220 to 300 ° C., the processing time may be set to 1 to 20 minutes. By setting the temperature and time in this way, the protein can be appropriately hydrolyzed and the solubilization rate of the protein can be increased. As a result, a polypeptide having a molecular weight of 100 to 10000 can be efficiently produced.
また、処理温度を130〜300℃、処理時間を5〜60分間とすることにより、生成するポリペプチドの分子量を100〜1000に制御することができる。 Further, by setting the treatment temperature to 130 to 300 ° C. and the treatment time to 5 to 60 minutes, the molecular weight of the produced polypeptide can be controlled to 100 to 1000.
本発明では、魚類または食肉を処理する際、水を添加してもよいが、添加しなくてもよい。本発明であれば、水を添加しなくても、魚類または食肉に含まれる水分によってタンパク質を十分に加水分解させることができる。 In the present invention, water may or may not be added when treating fish or meat. According to the present invention, the protein can be sufficiently hydrolyzed by the water contained in fish or meat without adding water.
また、本発明では、魚類または食肉を処理する際、水以外の成分を添加してもよいが、添加しなくてもよい。すなわち、本発明では、魚類または食肉のみを高温高圧処理に供してもよい。水以外の成分には、たとえば酸、塩基、還元剤、分散剤、界面活性剤および錯化剤等が含まれる。 Further, in the present invention, when treating fish or meat, components other than water may or may not be added. That is, in the present invention, only fish or meat may be subjected to high temperature and high pressure treatment. Ingredients other than water include, for example, acids, bases, reducing agents, dispersants, surfactants, complexing agents and the like.
本発明における魚類には、マグロ、カツオ、サケ、アジ、ブリおよびマダイなどが含まれる。本発明において、魚類は、好ましくはマグロまたはカツオである。本発明における魚類は、1種類の魚類であってもよいし、2種類以上の魚類の混合物であってもよい。魚類は、たとえば魚類のアラ、廃物および身などを用いることができる。魚類のアラには、頭部、骨、ヒレ、エラおよびこれらに付随する身などが含まれる。魚類のアラは、廃物であることが多いが、本発明では、アラから得た処理物を増殖促進剤の有効成分として利用できる。したがって、本発明における、魚類のアラを高温高圧処理して得られた処理物を有効成分として含有する増殖促進剤は、特に有用である。 Fish in the present invention include tuna, bonito, salmon, horse mackerel, yellowtail, red sea bream and the like. In the present invention, the fish is preferably tuna or bonito. The fish in the present invention may be one kind of fish or a mixture of two or more kinds of fish. As the fish, for example, fish ara, waste and flesh can be used. Fish gills include heads, bones, fins, gills and their associated bodies. Fish ara is often a waste product, but in the present invention, a processed product obtained from ara can be used as an active ingredient of a growth promoter. Therefore, in the present invention, the growth promoter containing a treated product obtained by treating fish ara at high temperature and high pressure as an active ingredient is particularly useful.
本発明における食肉には、牛肉、豚肉、鶏肉、猪肉、羊肉、鹿肉、馬肉、熊肉、鰐肉および鯨肉などが含まれる。本発明における食肉は、1種類の食肉であってもよいし、2種類以上の食肉の混合物であってもよい。また、食肉は、動物のいずれの部分であってもよい。たとえば、鶏肉としては、むね肉、ささみ、もも肉、すね肉および手羽などを用いることができる。 Meat in the present invention includes beef, pork, chicken, wild boar meat, sheep meat, venison, horse meat, bear meat, eel meat, whale meat and the like. The meat in the present invention may be one kind of meat or a mixture of two or more kinds of meat. Also, the meat may be any part of the animal. For example, as chicken, breast meat, chicken breast, thigh meat, shin meat, chicken wings and the like can be used.
魚類または食肉は、高温高圧処理する前に煮熟圧搾してもよい。たとえば、魚類または食肉は、プレスケーキとして提供されてもよい。プレスケーキは、たとえば以下の通りに製造することができる:1.魚類または食肉を同量程度の水とともに釜で90〜100℃にて1〜2時間煮熟する。2.次いで、煮熟した後の魚類または食肉由来の固形分を圧搾機で圧搾し、固液分離した後に残った固形分をプレスケーキとする。 Fish or meat may be boiled and squeezed before high temperature and high pressure treatment. For example, fish or meat may be served as a press cake. Press cakes can be produced, for example, as follows: 1. Boil fish or meat in a kettle with about the same amount of water for 1-2 hours at 90-100 ° C. 2. Next, the solid content derived from fish or meat after simmering is squeezed with a squeezing machine, and the solid content remaining after solid-liquid separation is used as a press cake.
本発明の増殖促進剤は、さらに任意の成分を含むことができる。たとえば、本発明の増殖促進剤は、薬学的に許容される基剤、担体、添加剤、賦形剤、結合剤、崩壊剤、滑沢剤、安定化剤、着色剤、pH調節剤、緩衝剤および可溶化剤などを含むことができる。 The growth promoter of the present invention can further contain any component. For example, the growth promoters of the present invention are pharmaceutically acceptable bases, carriers, additives, excipients, binders, disintegrants, lubricants, stabilizers, colorants, pH regulators, buffers. Agents, solubilizers and the like can be included.
本発明の増殖促進剤は、固体、液体、粉体、粒体およびペーストなどの任意の形態であることができる。また、本発明の増殖促進剤は、経口投与製剤として、錠剤、トローチ剤、丸剤、散剤、カプセル剤、顆粒剤、懸濁剤、乳剤、シロップ剤および液剤などの任意の製剤であることができる。また、本発明の増殖促進剤は、非経口投与製剤であってもよく、たとえば静脈注射、皮下注射、腹腔内注射、筋肉内注射、経皮投与、経鼻投与、経肺投与、経腸投与、口腔内投与および経粘膜投与などの投与のための任意の製剤であることができる。 The growth promoter of the present invention can be in any form such as solid, liquid, powder, granules and paste. In addition, the growth promoter of the present invention may be any preparation such as tablets, lozenges, pills, powders, capsules, granules, suspensions, emulsions, syrups and liquids as orally administered preparations. can. The growth promoter of the present invention may be a parenteral administration preparation, for example, intravenous injection, subcutaneous injection, intraperitoneal injection, intramuscular injection, transdermal administration, nasal administration, enteral administration, enteral administration. It can be any formulation for administration, such as oral administration and transmucosal administration.
本発明の増殖促進剤は、間葉系幹細胞に添加して培養することにより、間葉系幹細胞の増殖を促進することができる。したがって、間葉系幹細胞を用いた再生医療に特に有用である。また、本発明の増殖促進剤は、ヒトおよびヒト以外の動物に対して投与することにより、生体内において間葉系幹細胞の増殖を促進することも可能である。 The growth promoter of the present invention can promote the growth of mesenchymal stem cells by adding it to the mesenchymal stem cells and culturing the cells. Therefore, it is particularly useful for regenerative medicine using mesenchymal stem cells. In addition, the growth promoter of the present invention can promote the growth of mesenchymal stem cells in vivo by administering to humans and animals other than humans.
本発明はまた、魚類または食肉を100〜300℃の温度および0.1〜8.6MPaの圧力において1〜120分間処理した処理物を有効成分として含有する、間葉系幹細胞の増殖を促進するための食品組成物を提供する。 The present invention also comprises a food product for promoting the proliferation of mesenchymal stem cells, which comprises a processed product obtained by treating fish or meat at a temperature of 100 to 300 ° C. and a pressure of 0.1 to 8.6 MPa for 1 to 120 minutes as an active ingredient. The composition is provided.
本発明の食品組成物は、栄養補助食品、サプリメント、保健機能食品、特定保健用食品および栄養機能食品などとして提供することができる。本発明の食品組成物は、間葉系幹細胞の増殖を促進する等の機能を表示した食品であってもよい。また、本発明の食品組成物は、一般的な加工された食品の形態であってもよく、たとえば飲料品、菓子類、スープ類、乳製品、油脂加工品および調味料などの任意の形態であることができる。 The food composition of the present invention can be provided as a dietary supplement, a supplement, a food with a health function, a food for specified health use, a food with a nutritional function, and the like. The food composition of the present invention may be a food exhibiting a function such as promoting the proliferation of mesenchymal stem cells. In addition, the food composition of the present invention may be in the form of a general processed food, for example, in any form such as beverages, confectionery, soups, dairy products, processed fats and oils and seasonings. There can be.
(実施例1)マグロ廃棄部の可溶化物(TWL)の分子量分布
以下の方法により、マグロ廃棄部の可溶化物(TWL)を調製した。マグロは三幾飼料工業株式会社から提供された。マグロから可食部を取り除いた廃棄部(頭および骨など)を用いた。50ml耐圧容器に、マグロ廃棄部の身(以下、「身」と表記する)または廃棄部の身をできるだけ除去した骨(以下、「骨」と表記する)15gを入れ、250℃または200℃で5分、15分、20分、30分または60分間、4.1MPaにおいて高温高圧処理をし、マグロ廃棄部可溶化物(TWL)を得た。高温高圧処理のイメージ図を図1に示す。マグロ廃棄部を入れた耐圧容器を、ヒーターにより加熱した溶融塩炉内に置くことで、高温高圧処理した。溶融塩炉の温度は熱電対により測定した。処理時間は、耐圧容器を溶融塩炉に入れた時から取り出す時までとした。所定時間後、耐圧容器を溶融塩炉から取りだして、常温の水浴に浸すことで冷却し、処理を終了した。
(Example 1) Molecular weight distribution of solubilized tuna (TWL) in the tuna waste part A solubilized product (TWL) in the tuna waste part was prepared by the following method. Tuna was provided by Saniku Feed Industry Co., Ltd. The waste part (head and bone, etc.) from which the edible part was removed from the tuna was used. In a 50 ml pressure-resistant container, put 15 g of the body of the tuna disposal part (hereinafter referred to as "body") or the bone from which the body of the waste part has been removed as much as possible (hereinafter referred to as "bone"), and at 250 ° C or 200 ° C. High-temperature and high-pressure treatment was carried out at 4.1 MPa for 5 minutes, 15 minutes, 20 minutes, 30 minutes or 60 minutes to obtain a solubilized tuna waste portion (TWL). Figure 1 shows an image of high-temperature and high-pressure processing. The pressure-resistant container containing the tuna disposal part was placed in a molten salt reactor heated by a heater to perform high-temperature and high-pressure treatment. The temperature of the molten salt reactor was measured with a thermocouple. The treatment time was from the time when the pressure-resistant container was put into the molten salt reactor to the time when it was taken out. After a predetermined time, the pressure-resistant container was taken out from the molten salt reactor and cooled by immersing it in a water bath at room temperature to complete the treatment.
得られた高温高圧処理物の遠心上清について、分子量分布を測定した。分子量分布は、HPLCを用いてゲルろ過クロマトグラフィーにより測定した(カラム:TSK-GEL G2500PWXL 7.8×300mm;溶離液:0.1%TFA:CH3CN=55:45;流速:0.5ml/min;温度:40℃;検出:UV at 210nm)。 The molecular weight distribution of the obtained centrifugal supernatant of the high-temperature and high-pressure treated product was measured. The molecular weight distribution was measured by gel filtration chromatography using HPLC (column: TSK-GEL G2500PWXL 7.8 x 300 mm; eluent: 0.1% TFA: CH 3 CN = 55: 45; flow velocity: 0.5 ml / min; temperature: 40 ° C; detection: UV at 210 nm).
これらの試料(TWL)の分子量分布を測定した結果を図2〜5に示す。図2〜5のグラフにおいて、横軸はHPLCの溶出時間を表し、縦軸は吸光度(AU:Absorbance units)を表す。 The results of measuring the molecular weight distribution of these samples (TWL) are shown in FIGS. 2 to 5. In the graphs of FIGS. 2 to 5, the horizontal axis represents the elution time of HPLC, and the vertical axis represents the absorbance (AU).
図2は、マグロ廃棄部の骨を250℃で処理した可溶化物の分子量分布を示す。 FIG. 2 shows the molecular weight distribution of the solubilized product obtained by treating the bone of the tuna waste portion at 250 ° C.
図3は、マグロ廃棄部の身を250℃で処理した可溶化物の分子量分布を示す。 FIG. 3 shows the molecular weight distribution of the solubilized tuna waste treated at 250 ° C.
図4は、マグロ廃棄部の骨を200℃で処理した可溶化物の分子量分布を示す。 FIG. 4 shows the molecular weight distribution of the solubilized product obtained by treating the bone of the tuna waste portion at 200 ° C.
図5は、マグロ廃棄部の身を200℃で処理した可溶化物の分子量分布を示す。 FIG. 5 shows the molecular weight distribution of the solubilized tuna waste treated at 200 ° C.
図2〜5に示すように、処理時間が長くなるほど、主要な成分の分子量が1000以上から100以下へと減少していた。特に250℃15〜30分の条件で得られた試料は、低分子側の1000以上から100にピークが見られたため、アミノ酸10個以下のペプチドが多いと考えられる。 As shown in FIGS. 2 to 5, the molecular weight of the main component decreased from 1000 or more to 100 or less as the treatment time became longer. In particular, the samples obtained under the conditions of 250 ° C. for 15 to 30 minutes showed peaks from 1000 or more to 100 on the small molecule side, so it is considered that there are many peptides with 10 or less amino acids.
(実施例2)マグロ廃棄部の可溶化物(TWL)のアミノ酸分析
以下の方法により、マグロ廃棄部の可溶化物(TWL)を調製した。マグロは三幾飼料工業株式会社から提供された。マグロから可食部を取り除いた廃棄部(頭および骨など)を用いた。50ml耐圧容器に、マグロ廃棄部の身(以下、「身」と表記する)または廃棄部の身をできるだけ除去した骨(以下、「骨」と表記する)を入れ、200℃30分間1.6 MPa、250℃15分間または250℃30分間、4.1 MPaにおいて高温高圧処理をし、マグロ廃棄部可溶化物(TWL)を得た。高温高圧処理は、実施例1と同様に、図1の装置を使用し、マグロ廃棄部を入れた耐圧容器を、ヒーターにより加熱した溶融塩炉内に置くことで、高温高圧処理した。溶融塩炉の温度は熱電対により測定した。処理時間は、耐圧容器を溶融塩炉に入れた時から取り出す時までとした。15分または30分後、耐圧容器を溶融塩炉から取りだして、常温の水浴に浸すことで冷却し、処理を終了した。
(Example 2) Amino acid analysis of solubilized tuna waste (TWL) A solubilized tuna waste (TWL) was prepared by the following method. Tuna was provided by Saniku Feed Industry Co., Ltd. The waste part (head and bone, etc.) from which the edible part was removed from the tuna was used. In a 50 ml pressure-resistant container, put the body of the tuna disposal part (hereinafter referred to as "body") or the bone from which the body of the disposal part has been removed as much as possible (hereinafter referred to as "bone"), and put it at 200 ° C for 30 minutes at 1.6 MPa. High temperature and high pressure treatment was carried out at 250 ° C. for 15 minutes or 250 ° C. for 30 minutes at 4.1 MPa to obtain a solubilized tuna waste portion (TWL). The high-temperature and high-pressure treatment was carried out by using the apparatus shown in FIG. 1 and placing a pressure-resistant container containing a tuna disposal part in a molten salt reactor heated by a heater, as in Example 1. The temperature of the molten salt reactor was measured with a thermocouple. The treatment time was from the time when the pressure-resistant container was put into the molten salt reactor to the time when it was taken out. After 15 or 30 minutes, the pressure-resistant container was taken out of the molten salt reactor and cooled by immersing it in a water bath at room temperature to complete the treatment.
得られたTWLのアミノ酸分析を行った。高温高圧処理した処理物を遠心分離して、その上清を回収した。得られた遠心上清について、、遊離アミノ酸量および全アミノ酸量を測定した。遊離アミノ酸は、HPLCアミノ酸自動分析により測定した。また、全アミノ酸の量は、6N塩酸を用いて105℃で16時間分解した後塩酸を除去し、これを定容してHPLCアミノ酸自動分析に供することにより、測定した。 Amino acid analysis of the obtained TWL was performed. The processed product treated at high temperature and high pressure was centrifuged, and the supernatant was collected. The amount of free amino acids and the total amount of amino acids were measured in the obtained centrifugal supernatant. Free amino acids were measured by automatic HPLC amino acid analysis. The amount of total amino acids was measured by decomposing at 105 ° C. for 16 hours with 6N hydrochloric acid, removing the hydrochloric acid, and subjecting this to automatic HPLC amino acid analysis.
「骨」または「身」から250℃15分または30分の条件で得られたTWLのアミノ酸分析結果を表1に示す。表1に示すように、これらのTWLに含有されるアミノ酸は、アスパラギン酸(Asp)、グルタミン酸(Glu)、プロリン(Pro)、グリシン(Gly)、アラニン(Ala)、バリン(Val)、メチオニン(Met)、イソロイシン(Ile)、ロイシン(Leu)、チロシン(Tyr)、フェニルアラニン(Phe)、ヒスチジン(His)、リシン(Lys)、アルギニン(Arg)およびヒドロキシプロリン(Hyp)であった。また、200℃30分の条件で得られたTWLは、トレオニン(Thr)およびセリン(Ser)を含んでいた Table 1 shows the amino acid analysis results of TWL obtained from "bone" or "body" at 250 ° C for 15 or 30 minutes. As shown in Table 1, the amino acids contained in these TWLs are aspartic acid (Asp), glutamate (Glu), proline (Pro), glycine (Gly), alanine (Ala), valine (Val), and methionine (Val). They were Met), isoleucine (Ile), leucine (Leu), tyrosine (Tyr), phenylalanine (Phe), histidine (His), lysine (Lys), arginine (Arg) and hydroxyproline (Hyp). In addition, the TWL obtained under the condition of 200 ° C. for 30 minutes contained threonine (Thr) and serine (Ser).
これらの結果から、マグロ廃棄部の可溶化物(TWL)には、グルタミン酸、アラニン、グリシン、プロリン、ヒドロキシプロリンおよびロイシンが多いことがわかった。マグロ廃棄部の可溶化物(TWL)のアミノ酸組成は、食品栄養成分表に記載されているマグロの身のアミノ酸組成とは異なっている。そのため、マグロ廃棄部の可溶化物(TWL)には、この部位特有のアミノ酸およびペプチドが含まれる可能性が示唆される。 From these results, it was found that the solubilized product (TWL) of the tuna waste part contains a large amount of glutamic acid, alanine, glycine, proline, hydroxyproline and leucine. The amino acid composition of the solubilized product (TWL) of the tuna waste part is different from the amino acid composition of the tuna meat described in the food nutrition ingredient table. Therefore, it is suggested that the solubilized product (TWL) of the tuna waste part may contain amino acids and peptides peculiar to this site.
(実施例3)マグロ廃棄部の可溶化物(TWL)の幹細胞に対する影響
(骨髄由来の間葉系幹細胞の初代培養)
5週齢以上のddy雄性及び雌性マウス(東京実験動物株式会社、東京、日本)を用いた。マウスの大腿骨および脛骨を各2本ずつ摘出し、両骨端2mmを切断後、回転数6000rpm、遠心力2000×gで遠心(Fisher Scientific)し、骨髄液を回収した。骨髄液を5%FBS(シグマアルドリッチジャパン合同会社 Lot:15K111)および抗生物質(48unit/ml Penicillin、50μg/ml Streptomycin)を含有するMinimum Essential Alpha Medium (ライフテクノロジーズジャパン株式会社、東京、日本)10mlで懸濁した。次いで、cell strainer(FALCON、神奈川、日本)を用いて肉片などを除去し、100mm dish(コーニングジャパン株式会社、東京、日本)に播種して、37℃、5%CO2条件下で3日間培養した。その後、ダルベッコPBS (-) (日水製薬株式会社、東京、日本)洗浄により浮遊細胞を取り除き、得られた接着細胞をマウス骨髄由来間葉系幹細胞(BMSC)とした。生細胞数はLuna-FL(細胞測定器)(LMS)を用いて計測した。
(Example 3) Effect of solubilized tuna (TWL) on stem cells (primary culture of bone marrow-derived mesenchymal stem cells)
Ddy male and female mice aged 5 weeks or older (Tokyo Experimental Animal Co., Ltd., Tokyo, Japan) were used. Two femurs and two tibias of mice were removed, and 2 mm of both epiphysis were cut, and then centrifuged at a rotation speed of 6000 rpm and a centrifugal force of 2000 × g (Fisher Scientific) to collect bone marrow fluid. Minimum Essential Alpha Medium (Life Technologies Japan Co., Ltd., Tokyo, Japan) containing 5% FBS (Sigma-Aldrich Japan LLC Lot: 15K111) and antibiotics (48unit / ml Penicillin, 50μg / ml Streptomycin) Suspended. Next, remove meat pieces using a cell strainer (FALCON, Kanagawa, Japan), sow in a 100 mm dish (Corning Japan Co., Ltd., Tokyo, Japan), and incubate for 3 days under 37 ° C, 5% CO 2 conditions. bottom. Then, the floating cells were removed by washing with Dulbecco PBS (-) (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan), and the obtained adherent cells were used as mouse bone marrow-derived mesenchymal stem cells (BMSC). The number of viable cells was measured using a Luna-FL (cell measuring device) (LMS).
(細胞増殖評価(WST-1法))
サンプルには、250℃30分の高温高圧処理により得られたマグロ廃棄物の骨の可溶化物(TWL:骨250℃30分)を用いた。また、対照として、アミノ酸スコアが100のウシ由来カゼインをトリプシンで低分子化したトリプトン(Trypton)を用いた。
(Cell proliferation evaluation (WST-1 method))
As a sample, a solubilized bone of tuna waste obtained by high-temperature and high-pressure treatment at 250 ° C. for 30 minutes (TWL:
100mm dishに接着している骨髄由来間葉系幹細胞(BMSC)をダルベッコPBS (-)で洗浄後、CELL LIFTERを用いて剥離し、96 well plate に8.0×103cells/wellで播種した。一日後、マグロ廃棄部の可溶化物(TWL)またはトリプトン(Trypton)(対照)を添加し、6日後に細胞増殖試験試薬WST-1(ロシュ・ダイアグノスティックス株式会社、東京、日本)を終濃度10%になるように培地に溶解し、全量培地交換を行った。37℃、5%CO2条件下でインキュベートし、1時間後に440nmの吸光度をSpectra Max M2e(モレキュラーデバイスジャパン株式会社、東京、日本)にて測定した。結果は、各試料の添加時を1として6日後の増殖率を相対的に示した。表2は、4つの独立したウェルにおける増殖率の平均値および標準誤差を示す。 Bone marrow-derived mesenchymal stem cells (BMSC) adhering to a 100 mm dish were washed with Dulbecco PBS (-), exfoliated using CELL LIFTER, and seeded on a 96-well plate at 8.0 × 10 3 cells / well. One day later, solubilized tuna (TWL) or tryptone (control) was added, and six days later, the cell proliferation test reagent WST-1 (Roche Diagnostics Co., Ltd., Tokyo, Japan) was added. The solution was dissolved in the medium to a final concentration of 10%, and the whole amount of the medium was replaced. Incubation was carried out under 37 ° C. and 5% CO 2 conditions, and after 1 hour, the absorbance at 440 nm was measured with Spectra Max M2e (Molecular Device Japan Co., Ltd., Tokyo, Japan). The results showed the relative growth rate after 6 days, with the addition of each sample as 1. Table 2 shows the mean and standard errors of growth rates in the four independent wells.
また、結果を図6にグラフとしてに示してある。図6は、4ウェルの平均±標準誤差を示す。**は、p<0.01を示す。 The results are shown in a graph in Fig. 6. Figure 6 shows the 4-well mean ± standard error. ** indicates p <0.01.
図6においてnoramalは、何も添加していない対照を示す。図6には、何も添加していない対照normalを1とし、各濃度のTWLおよびトリプトンを添加したときの相対的な細胞増殖率を示している。図6に示すように、通常培地のみで培養した細胞(Normal群)およびトリプトンを添加した群と比較して、TWLを間葉系幹細胞に添加した群では、濃度依存的に有意に細胞増殖が促進された。特にTWLを100μg/mLにて添加した場合には、Normal群と比較して約1.8倍の細胞増殖が観察された。 In FIG. 6, noramal indicates a control to which nothing was added. FIG. 6 shows the relative cell proliferation rate when TWL and tryptone at each concentration were added, with the control normal to which nothing was added as 1. As shown in FIG. 6, compared with the cells cultured only in the normal medium (Normal group) and the group to which tryptone was added, the group to which TWL was added to the mesenchymal stem cells showed significant cell proliferation in a concentration-dependent manner. Promoted. In particular, when TWL was added at 100 μg / mL, cell proliferation was observed about 1.8 times that of the Normal group.
(実施例3)ペプトン類の幹細胞に対する影響
(骨髄由来の間葉系幹細胞の初代培養)
実施例3と同様の手順で骨髄由来の間葉系幹細胞の初代培養を調製した。
(Example 3) Effect of peptones on stem cells (primary culture of bone marrow-derived mesenchymal stem cells)
A primary culture of bone marrow-derived mesenchymal stem cells was prepared in the same procedure as in Example 3.
ペプトン類は、市販のものを購入した。実験に使用したペプトン類は以下のとおりである。なお、ペプトンは、タンパク質を酵素処理して低分子化(オリゴペプチド)した物質の総称である。
1.トリプトン(Try)(カゼインのトリプシン消化物)
2.ラクトアルブミン加水分解物 (LAH)
3.カゼインペプトン (Cpe)(カゼインのペプシン消化物)
4.牛肉由来ペプトン (Mpe)
5.大豆由来ペプトン (Spe)
Peptones were purchased commercially. The peptones used in the experiment are as follows. Peptone is a general term for substances in which proteins are enzymatically treated to reduce their molecular weight (oligopeptides).
1. 1. Tryptone (trypsin digest of casein)
2. Lactalbumin hydrolyzate (LAH)
3. 3. Casein Peptone (Cpe) (Pepsin digest of casein)
4. Beef-derived peptone (Mpe)
5. Soybean-derived peptone (Spe)
(細胞増殖評価(WST-1法))
サンプルには、上記のペプトン類、すなわちトリプトン(Try)、ラクトアルブミン加水分解物(LAH)、カゼインペプトン(Cpe)、牛肉由来ペプトン(Mpe)および大豆由来ペプトン(Spe)を用いた。また、
(Cell proliferation evaluation (WST-1 method))
The above peptones, namely tryptone (Try), lactalbumin hydrolyzate (LAH), casein peptone (Cpe), beef-derived peptone (Mpe) and soybean-derived peptone (Spe) were used as samples. again,
100mm dishに接着している骨髄由来間葉系幹細胞(BMSC)をダルベッコPBS (-)で洗浄後、CELL LIFTERを用いて剥離し、96 well plate に8.0×10³ cells/wellで播種した。一日後、ペプトン類を添加し、6日後に細胞増殖試験試薬WST-1(ロシュ・ダイアグノスティックス株式会社、東京、日本)を終濃度100μg/mlになるように培地に溶解し、全量培地交換を行った。37℃、5%CO₂条件下でインキュベートし、1時間後に440nmの吸光度をSpectra Max M2e(モレキュラーデバイスジャパン株式会社、東京、日本)にて測定した。その結果を表3および図7に示す。 Bone marrow-derived mesenchymal stem cells (BMSC) adhering to a 100 mm dish were washed with Dulbecco PBS (-), exfoliated using CELL LIFTER, and seeded on a 96-well plate at 8.0 × 10 ³ cells / well. One day later, peptones were added, and six days later, the cell proliferation test reagent WST-1 (Roche Diagnostics Co., Ltd., Tokyo, Japan) was dissolved in the medium to a final concentration of 100 μg / ml, and the total amount was medium. Exchanged. Incubation was carried out under 37 ° C. and 5% CO ₂ conditions, and after 1 hour, the absorbance at 440 nm was measured with Spectra Max M2e (Molecular Device Japan Co., Ltd., Tokyo, Japan). The results are shown in Table 3 and FIG.
表3および図7において、Nは、何も添加していない対照を示す。結果は、4つの独立したウェルにおける平均値±標準誤差を示す。結果は、各試料の添加時を1として6日後の増殖率を相対的に示した。図7に示すように、ペプトン類を添加した群では、骨髄由来間葉系幹細胞に対する細胞増殖活性は、観察されなかった。種々のアミノ酸やオリゴペプチドを含有しているペプトン類は、骨髄由来間葉系幹細胞の増殖に影響を与えないことが明らかとなった。 In Table 3 and FIG. 7, N indicates a control with no addition. The results show mean ± standard error in 4 independent wells. The results showed the relative growth rate after 6 days, with the addition of each sample as 1. As shown in FIG. 7, no cell proliferation activity against bone marrow-derived mesenchymal stem cells was observed in the group to which peptones were added. It was revealed that peptones containing various amino acids and oligopeptides do not affect the proliferation of bone marrow-derived mesenchymal stem cells.
実施例2および3の結果から、マグロアラ高温高圧処理物に含まれるペプチドは、カゼイン、牛肉、大豆由来の分解物とは異なる特徴的な成分を含有している可能性が高いことが明らかとなった。 From the results of Examples 2 and 3, it was clarified that the peptides contained in the tuna high-temperature and high-pressure treated products are likely to contain characteristic components different from those of casein, beef, and soybean-derived decomposition products. rice field.
本発明は、間葉系幹細胞の増殖を促進するため、間葉系幹細胞を用いた再生医療の分野に好適に利用できる。 Since the present invention promotes the proliferation of mesenchymal stem cells, it can be suitably used in the field of regenerative medicine using mesenchymal stem cells.
Claims (6)
The growth promoter for mesenchymal stem cells according to claim 4, wherein the fish is ara.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020068105A JP2021164407A (en) | 2020-04-06 | 2020-04-06 | Growth stimulator for mesenchymal stem cell |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020068105A JP2021164407A (en) | 2020-04-06 | 2020-04-06 | Growth stimulator for mesenchymal stem cell |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2021164407A true JP2021164407A (en) | 2021-10-14 |
Family
ID=78021209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020068105A Pending JP2021164407A (en) | 2020-04-06 | 2020-04-06 | Growth stimulator for mesenchymal stem cell |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2021164407A (en) |
-
2020
- 2020-04-06 JP JP2020068105A patent/JP2021164407A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yu et al. | Purification and identification of anti-inflammatory peptides from spent hen muscle proteins hydrolysate | |
Akagündüz et al. | Sea bream bones and scales as a source of gelatin and ACE inhibitory peptides | |
JP5689222B2 (en) | Collagen peptide composition and food and drink containing the same | |
JP3929088B2 (en) | Bone formation promoter and bone resorption inhibitor | |
CN101466389A (en) | Formulation comprising whey protein and hydrolysates for improving muscle recovery | |
JP5213332B2 (en) | Egg-derived bone strengthening composition | |
KR0161747B1 (en) | Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient | |
JP2007523045A (en) | Bioactive peptide derived from egg white protein by enzymatic hydrolysis | |
WO2016068338A1 (en) | Hair growth promoter and use therefor | |
JPH09227403A (en) | Osteogenic promoting and bone resorption preventing agent | |
Ibarz-Blanch et al. | Chicken slaughterhouse by-products: A source of protein hydrolysates to manage non-communicable diseases | |
Koyama | Effects of collagen ingestion and their biological significance | |
Zhang et al. | Silver carp (Hypophthalmichthys molitrix) by-product hydrolysates: A new nitrogen source for Bifidobacterium animalis ssp. lactis BB-12 | |
JP6411455B2 (en) | Peptide having osteoblast proliferation promoting activity and use thereof | |
WO2014007318A1 (en) | Cartilage cell growth promoter | |
Martínez‐Alvarez | Hormone‐like peptides obtained by marine‐protein hydrolysis and their bioactivities | |
CN1894273A (en) | Peptide inhibiting angiotensin converting enzyme | |
JP2021164407A (en) | Growth stimulator for mesenchymal stem cell | |
JP6143218B2 (en) | Tendon and ligament function improving agent and pharmaceutical composition, food and feed containing the same | |
JP2020518572A (en) | Flounder ground meat having antioxidative and antihypertensive effects and method for producing the same | |
JP2002326951A (en) | Blood sugar level increase inhibitor | |
EP0754699A1 (en) | Completely dissolved bone tissue and method for producing the same | |
JP2021164406A (en) | Osteoclast differentiation inhibitor | |
TWI457131B (en) | Peptides and use thereof in the inhibition of angiotensin converting enzyme | |
JP2010001262A (en) | Functional composition and health maintenance food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230404 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240617 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240815 |